The online teaching service was valued at $800m in a Fidelity-led round, adding to earlier funding from investors such as Bloomberg Beta, WME Ventures and Novel TMT.

Tencent and Unilever Ventures have participated in a series B round for the business accounting platform developer, reportedly valuing it at up to $300m.

The corporate-backed health management service raised the cash from Perceptive Advisors and has used $30m to buy musculoskeletal-focused Physera.

Guangzhou Honest Dairy's yoghurt brand has spun off with $56.3m in a round led by Matrix Partners China that will fund the strengthening of its production resources.

Capital One Ventures was among the participants as e-commerce focused cybersecurity provider Source Defense sealed $10.5m of series A funding.

The customer service technology developer has raised $21.1m from investors including Beijing Kunlun Technology in a round co-led by Blue Lake Capital and Eastern Bell Venture Capital.

Existing investors Cavallo Ventures and Syngenta Ventures returned to reinvest in the crop production technology developer’s series C round.

GV and Illumina Ventures returned to reinvest in cellular therapy developer SQZ Biotechnologies, an MIT spinout that has now raised at least $166m to date.

SoftBank Vision Fund has invested $200m in the construction services provider, which announced the round at the same time as chief operating officer Paal Kibsgaard's ascendancy to CEO.

The rare disease drug developer pulled in $145m through a round led by Pivotal BioVenture Partners and backed by Mitsui and Fidelity.